Medical Products Liability Posts in November, 2014

The Many Side Effects of SSRI Therapy

Many risks of anti-depressants are relatively well-known and publicized. One of the most common side effects of anti-depressants occurs when expectant mothers take them. Selective Serotonin Reuptake Inhibitor antidepressants (SSRIs) have a very high risk of resulting in birth defects in a newborn, reports the National Library of Medicine, part of the National Institute for Health (NIH)....
Continue Reading »

More Research On The Dangers Of Metal-on-Metal Hip Implants

An international group of scientists recently condemned Metal-on-Metal hip replacement implants. A report issued by the European Commission’s Scientific Committee on Emerging Newly Identified Health Risks concluded that metal-on-metal (MoM) devices should be “avoided” due to their “high failure rate.” Researchers stated that MoMs should be used only on a case-by-case basis, in light of other, more effective available alternatives....
Continue Reading »

FDA Issues Largest-Ever Medical Product Recall in 2014

The U.S. Food and Drug Administration (FDA) issued its largest recall of medical products ever in 2014, according to the Regulatory Affairs Professional Society (RAPS). The recall, posted to the FDA’s website in August, was of 233 Class I products manufactured by Puerto Rico-based Customed....
Continue Reading »

Dangers of FDA 501(k) Classification

When new products or medical devices are considered for approval for the consumer market, manufacturers must first undergo a rigorous system to have the device approved. The U.S. Food and Drug Administration (FDA) divides approved medical devices into three categories: Class I, II, and III. Class I devices are not subject to as much regulatory control as Class III—Class III devices are usually those which carry a greater risk to the patient or consumer....
Continue Reading »

Testosterone Therapy Gel Manufacturer Faces Lawsuits

In recent years, testosterone therapies to help men with erectile dysfunction or low testosterone levels have become more common than ever. With the advances in such medication, however, come advances in risks that accompany such treatment. According to WebMD.com, testosterone replacement therapy (TRT), are not as common as one may think....
Continue Reading »
  • Newland & Newland LLP, Attorneys, Arlington Heights, IL
  • Lawyer.com